Practical challenges associated with efanesoctocog alfa (ALTUVIIIO) prophylaxis in a 19‐month‐old male with severe hemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Practical challenges associated with efanesoctocog alfa (ALTUVIIIO) prophylaxis in a 19‐month‐old male with severe hemophilia A

Published:2024-05-16 Issue:8 Volume:71 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Mistretta Jessica N.¹^ORCID,Español Maria G.¹²,Tarantino Michael D.¹²,Christ Dane C.¹,Jones Maureen D.¹,Roberts Jonathan C.¹²^ORCID

Affiliation:

1. Bleeding & Clotting Disorders Institute, Dills Family Foundation Center for Research at BCDI Peoria Illinois USA

2. Departments of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Peoria Illinois USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.31081

Reference6 articles.

1. Hemophilia: The Past, the Present, and the Future

2. WFH Guidelines for the Management of Hemophilia, 3rd edition

3. BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A

4. Bioverativ Therapeutics Inc.Efanesoctocog alfa [antihemophilic factor (recombinant) Fc‐VWF‐XTEN fusion protein‐ehtl]: US prescribing information.Bioverativ Therapeutics Inc;2023.

5. MalecL PeyvandiF ChanAKC et al.Efanesoctocog alfa prophylaxis for previously treated patients <12 years of age with severe hemophilia A. ISTH 2023 Congress; June 24–28 2023. Abstract LB01.1.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP